MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Sleep disorders. See also Restless legs syndrome: Treatment"

  • 2026 International Congress

    Stellate Ganglion Block for Restless Legs Syndrome in a Patient with Renal Failure a Case Report

    Z. Zhang (Shanxi, China)

    Objective: To report a case of refractory restless legs syndrome (RLS) in a hemodialysis patient with renal failure who achieved significant symptom and sleep improvement…
  • 2026 International Congress

    Digital cognitive training and promoting a healthy lifestyle as a booster for cognitive reserve in prodromal Parkinson’s disease?

    A. Ophey, S. Röttgen, K. Kufer, J. Pauquet, D. Scharfenberg, P. Armbrust, A. Kammerzell, N. Knopf, S. Kollath, P. Sommer, CEJ. Doppler, E. Farrher, A. Seger, NJ. Shah, D. Zopfs, K. Reetz, GR. Fink, M. Sommerauer, E. Kalbe (Cologne, Germany)

    Objective: To investigate predictors of responsiveness to a multimodal cognitive training intervention in individuals with isolated REM sleep behavior disorder (iRBD). Background: The prodromal phase…
  • 2025 International Congress

    Qigong Exercise on Nonmotor Symptoms in Parkinson’s Disease

    W. Liu, I. Smirnova, Z. Liu, K. Lyons, R. Pahwa (Kansas City, USA)

    Objective: This randomized controlled clinical trial examined the efficacy of a Qigong exercise on non-motor symptoms in people with Parkinson’s disease (PD). Background: Non-motor symptoms…
  • 2025 International Congress

    Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

    A. Mahes, A. Wiltshire, M. San Luciano, S. Wang, J. Zuzuarregui (San Francisco, USA)

    Objective: This study evaluated one-year outcomes of Restless Legs Syndrome (RLS) in a cohort of patients with Parkinson’s disease (PD) who underwent deep brain stimulation…
  • 2024 International Congress

    ENLITE PD – A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson’s Disease

    A. Videnovic, E. Macklin, C. Coffey, M. Cudkowicz, HJ. Cho, J. Ohayon, A. Amara, K. Marder, P. Zee, C. Desir, H. Ernst, E. Steinhart, M. Costigan, A. Gudjonsdottir, D. Ecklund, M. Chase, S. Criswel, D. Charles, J. Coleman, A. Espay, A. Hung, S. Kadimi, A. Killoran, L. Luo, R. Malkani, J. Margolesky, J. Marsella, C. Maurer, D. Mihaila, P. Moretti, A. Park, P. Phielipp, H. Sarva, B. Shah, H. Shill, A. Siderowf, V. Suski, J. Tate, W. Tse, K. Wyant, L. Zhang, E. Klerman (Boston, USA)

    Objective: To determine if either once or twice-daily bright white light therapy (BWLT) improves sleep sufficiently relative to two control LT conditions to warrant proceeding…
  • 2024 International Congress

    Benzodiazepines in the Management of Restless Legs Syndrome: A Systematic Review and Meta-Analysis

    G. Bolner, H. Rodriguez, V. Xavier, A. Petry, M. da Rosa, A. Rossato, M. Felippe, T. Denicol, A. Hilbig (Porto Alegre, Brazil)

    Objective: To evaluate the efficacy and safety of benzodiazepines (BZD) as treatment for Restless Legs Syndrome (RLS), compared to placebo or other drugs. Background: RLS…
  • 2024 International Congress

    Sleep Characteristics in Idiopathic and Genetic Parkinson’s Disease

    A. Astefanous, M. Yang, D. Raymond, M. Rawal, J. Liang, A. Cohen, N. Becker, B. Plitnick, A. Yoo, V. Katsnelson, K. Leaver, S. Bressman, M. Figueiro, R. Saunders-Pullman, A. Wise (NEW YORK, USA)

    Objective: To investigate sleep features among individuals with genetic subgroups of PD, including LRRK2 G2019S-PD, GBA-PD, and iPD (idiopathic PD with no known genetic variant). Background:…
  • 2023 International Congress

    Ramelteon ameliorates abnormal sleep-wake behavior in a zebrafish model of Parkinson’s disease by facilitating abnormal lipid metabolism

    F. Wang, MZ. Pang, JY. Liu, CF. Liu (Suzhou, China)

    Objective: The study aims to explore the role of melatonin receptor 1 (MT1) in the regulation of sleep-wake behavior in rotenone-induced Parkinson's disease (PD) model…
  • 2023 International Congress

    Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device

    J. Thompson, L. Hirt, D. Kern, A. Baumgartner (AURORA, USA)

    Objective: Determine the viability of a wearable reduced montage EEG device to record sleep in a population of patients with Parkinson disease (PD). Background: Sleep…
  • 2023 International Congress

    Enhancement of deep sleep in people with Parkinson disease using auditory stimulation of slow waves at home

    SJ. Schreiner, S. Fattinger, J. Horlacher, G. da Poian, L. Kämpf, L. Brogli, W. Karlen, R. Huber, CR. Baumann, A. Maric (Zurich, Switzerland)

    Objective: To test the feasibility and effectivity of a new method for non-pharmacological enhancement of deep sleep in Parkinson disease (PD). Background: Sleep-wake disturbances and…
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley